[Logo Cambrex]



News Release


Date:         June 3, 2005
Contact:      Anne-Marie Hess
              Director, Investor Relations & Corporate Communications
Phone:        201-804-3062
Email:        annemarie.hess@cambrex.com
Release:      Immediate


             DAVID R. BETHUNE JOINS THE CAMBREX BOARD OF DIRECTORS
             -----------------------------------------------------

     East Rutherford, NJ - June 3, 2005 - Cambrex Corporation (NYSE: CBM), a
leading provider to the healthcare industry, is pleased to announce that David
R. Bethune was elected to the Cambrex Board of Directors on June 2, 2005.

     "David's vast healthcare experience and insights into the pharmaceutical
industry will be an invaluable asset to Cambrex and its Board of Directors as we
transition the business to specialty pharmaceuticals," commented James A. Mack,
Cambrex Chairman of the Board of Directors.

     David R. Bethune most recently was Chairman and Chief Executive Officer of
Atrix Laboratories, a drug delivery and product development company, where he
has been a director of the company for the past ten years. Prior to Atrix
Laboratories, he was President and Chief Operating Officer of IVAX Corporation,
a pharmaceutical company. Before joining IVAX, Mr. Bethune began a start-up
pharmaceutical company venture formed by Mayo Medical Ventures, a business unit
of Mayo Clinics of Rochester.

     Mr. Bethune previously served as group vice president of American Cyanamid
Company and a member of the Executive Committee where he had executive authority
for human biologicals, consumer health products, pharmaceuticals and ophthalmics
as well as global medical research. He was also President of the Lederle
Laboratories Division of American Cyanamid Company.

     Mr. Bethune received a B.A. degree in accounting and economics from
Lenior-Rhyne College, Hickory, North Carolina and Masters in Business
Administration in the Executive Program from Columbia University Graduate
School.


Cambrex Corporation | One Meadowlands Plaza | East Rutherford, NJ 07073
Phone 201.804.3000  | Fax 201.804.9852 | www.cambrex.com


About Cambrex
- -------------

        Cambrex is a global, diversified life sciences company dedicated to
providing products and services to accelerate and improve the discovery and
commercialization of human therapeutics. The Company employs approximately 1900
worldwide. For more information, please visit http://www.cambrex.com.

     Since the mid-1990's, Cambrex has helped customers develop their active
pharmaceutical ingredients (APIs) more efficiently and cost-effectively. The
Company has diagnosed and overcome problems that clients had in their
manufacturing processes, provided clinical or commercial quantities of hundreds
of pharmaceutical products and provided the analytical, regulatory and other
support services that clients need to shorten the time to market. More recently,
the Company expanded into the product commercialization arena with sales and
marketing services. The combined strength of experience, breadth of products and
services and success integrating over twenty acquisitions supports the Company's
strategy to move into the specialty therapeutics market.



                                     # # #